In Europe, this survival differential has been attributed to later stage of diagnosis, inadequacy of treatment, and barriers that the elderly face
in accessing cancer services [55, 56]. In the absence of research evidence in Mexico, reasons for this trend among elderly cohorts can only
be postulated from more generalised epidemiological cancer studies, the majority of which focus on breast and cervical cancer.